NCT01981239

Brief Summary

It was well known that aspiration is the primary cause of an aspiration pneumonia among the dysphagia patients. In order to predict the degree of an aspitation,video-fluoroscopic-swallowing study and fiberoptic-endoscopic swallowing evaluation have been developed, but those evaluations are invasive and allowed only in a limited condition. In this study, as a precedent study for the non-linear analysis, voice analysis using LPC method will be evaluated. The superiority of LPC method will be compared with a spectral analysis using Jitter and Simmer as a positive control. This clinical study will be performed prospective, positive-controlled, single-blind (i.e. assessor-blind),and single cohort clinical trial for efficacy

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2013

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

November 4, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 11, 2013

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

December 3, 2014

Status Verified

December 1, 2014

Enrollment Period

1.1 years

First QC Date

November 4, 2013

Last Update Submit

December 1, 2014

Conditions

Keywords

voice analysis aspiration prediction

Outcome Measures

Primary Outcomes (1)

  • LPC index

    Voice sampling before and immediately after drinking of 20ml N/S and linear analysis using LPC method

    one day before or after VFFS

Secondary Outcomes (3)

  • Spectral Analysis

    one day before or after VFFS

  • LPC anaysis

    one day after or before VFSS

  • Risk group

    whithin one hour of VFSS

Study Arms (2)

LPC analysis group

EXPERIMENTAL

Voice sampling is executed before and immediately after drinking of 20ml N/S and linear voice analyses using LPC method are performed to calculate LPC index, residual variance, coefficiency mean, coeffiency variance, and coeffiency skewness.

Device: VFSS

spectral analysis group

ACTIVE COMPARATOR

Voice sampling is executed before and immediately after drinking of 20ml N/S and spectral voice analyses using Dr. Speech program are performed to calculate HNR (dB), RAP (%: Jitter), Mean and SD Fundamental Frequency (Hz: Fo), Shimmer (%) and SNR (dB).

Device: VFSS

Interventions

VFSSDEVICE

VFSS was perfomred one day before or after the voice sampling in the same patients according to the guideline of modified Longeman's protocol.

LPC analysis groupspectral analysis group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who were referred for VFSS

You may not qualify if:

  • Patients cannot phonate d/t tracheostomy
  • Preexisting oro-laryngo-pharyngeal disease
  • Patients cannot follow 1 step command
  • Patients cannot maintain a phonation for 3 seconds
  • Refusal of participation
  • Patients who were not classified for the candidate by physicians
  • Patients who coughs following drinking of 5ml normal saline

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ulsan University Hospital

Ulsan, 682-714, South Korea

Location

MeSH Terms

Conditions

Deglutition Disorders

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Chang Ho Hwang, M.D. & Ph.D.

    Ulsan University Hospital

    STUDY DIRECTOR
  • Hyungseob Han, M.Sc.

    University of Ulsan

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 4, 2013

First Posted

November 11, 2013

Study Start

November 1, 2013

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

December 3, 2014

Record last verified: 2014-12

Locations